| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the … C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ... Journal of extracellular vesicles 7 (1), 1535750, 2018 | 8245 | 2018 |
| Systematic methodological evaluation of a multiplex bead-based flow cytometry assay for detection of extracellular vesicle surface signatures OPB Wiklander, RB Bostancioglu, JA Welsh, AM Zickler, F Murke, ... Frontiers in immunology 9, 1326, 2018 | 199 | 2018 |
| Dosing extracellular vesicles D Gupta, AM Zickler, S El Andaloussi Advanced drug delivery reviews 178, 113961, 2021 | 164 | 2021 |
| Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging D Gupta, X Liang, S Pavlova, OPB Wiklander, G Corso, Y Zhao, O Saher, ... Journal of extracellular vesicles 9 (1), 1800222, 2020 | 126 | 2020 |
| Identification of storage conditions stabilizing extracellular vesicles preparations A Görgens, G Corso, DW Hagey, R Jawad Wiklander, MO Gustafsson, ... Journal of extracellular vesicles 11 (6), e12238, 2022 | 113 | 2022 |
| Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type‐2 NF1 deletions AC Roehl, J Vogt, T Mussotter, AN Zickler, H Spöti, J Högel, ... Human mutation 31 (10), 1163-1173, 2010 | 43 | 2010 |
| Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading J Rädler, D Gupta, A Zickler, SEL Andaloussi Molecular Therapy 31 (5), 1231-1250, 2023 | 38 | 2023 |
| Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type‐3 NF1 deletions AM Zickler, S Hampp, L Messiaen, K Bengesser, T Mussotter, AC Roehl, ... Human Mutation 33 (2), 372-383, 2012 | 36 | 2012 |
| Functional extracellular vesicles aplenty AM Zickler, S El Andaloussi Nature biomedical engineering 4 (1), 9-11, 2020 | 26 | 2020 |
| Multimodal engineering of extracellular vesicles for efficient intracellular protein delivery X Liang, D Gupta, J Xie, EV Wonterghem, LV Hoecke, J Hean, Z Niu, ... bioRxiv, 2023.04. 30.535834, 2023 | 2 | 2023 |
| Novel endogenous engineering platform for robust loading and delivery of functional mRNA by extracellular vesicles AM Zickler, X Liang, M De Luca, D Gupta, G Corso, L Errichelli, J Hean, ... bioRxiv, 2023.03. 17.533081, 2023 | 2 | 2023 |
| Antibody Displaying Extracellular Vesicles (Fc-EVs) for Delivery of Tumor Targeted Therapeutics OPB Wiklander, R Jawad, DR Mamand, H Sharma, X Liang, D Gupta, ... MOLECULAR THERAPY 29 (4), 332-333, 2021 | 1 | 2021 |
| Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors X Liang, D Gupta, J Xie, E Wonterghem, L Hoecke, J Hean, Z Niu, ... | | 2023 |
| Exosome comprising stabilized rna therapeutics VC LLORENTE, X Liang, A Zickler, DE Mariacristina, L Errichelli, C Smith, ... US Patent App. 17/609,190, 2022 | | 2022 |
| Albumin-Decorated Exosomes Demonstrate Extended Circulation Time In Vivo X Liang, D Gupta, V Galli, W Zheng, C Davies, J Hean, E Kyriakopoulou, ... MOLECULAR THERAPY 29 (4), 220-220, 2021 | | 2021 |
| α-Catenin is a dosage-dependent tumor suppressor gene in MDS AM Zickler Dissertation, Duisburg, Essen, Universität Duisburg-Essen, 2016, 2018 | | 2018 |
| Intrachromosomal mitotic non-allelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions H Kehrer-Sawatzki, A Roehl, J Vogt, T Mussotter, A Zickler, H Spoeri, ... Wiley-Blackwell, 2011 | | 2011 |
André GörgensResearcher, Karolinska Institutet, Stockholm, SwedenVerified email at ki.se
